Literature DB >> 34713329

Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.

Yuling Yan1,2, Xian Xing1,2, Xiaoze Wang1,2, Li Yang3,4.   

Abstract

OBJECTIVES: To investigate the usefulness of the criteria with liver stiffness (LS) measured by two-dimensional shear wave elastography (2D-SWE) and platelet count (PLT) for ruling out high-risk varices in patients with compensated advanced chronic liver disease (cACLD).
METHODS: A total of 661 patients with cACLD had successfully undergone 2D-SWE and endoscopy screening. We analyzed risk factors for the presence of high-risk varices and compared proportions of patients who were spared endoscopy when used the predicting criteria with LS (ranged from 16 to 25 kPa) and PLT (ranged from 80 × 109/L to 150 × 109/L).
RESULTS: PLT, albumin, LS were found to be independent predictors of high-risk varices. The LS values for ruling out and ruling in high-risk varices were 14.0 kPa and 24.8 kPa, respectively. When the Baveno VI criteria LS < 20 kPa and PLT > 150 × 109/L were used, the high-risk varices miss rate was 2.1%, while the saved endoscopy rate only was 19.2%. The new criteria that LS < 16 kPa and PLT > 100 × 109/L saved 30.4-34.6% endoscopy with 0-3.2% high-risk varices miss rate in the subgroup analysis stratified according to the types of underlying liver disease.
CONCLUSIONS: The Baveno VI criteria can be applied to LS measurement by 2D-SWE. The new criteria that LS < 16 kPa and PLT > 100 × 109/L could be a potential model to spare more endoscopy screening with < 5% high-risk varices miss rate. KEY POINTS: • LS measured by 2D-SWE is reliable predictive factor for predicting all-size varices and high-risk varices in patients with compensated advanced chronic liver disease. • LS measured by 2D-SWE < 16 kPa and PLT > 100 × 109 /L, which can spare more endoscopy than Baveno VI criteria with < 5% high-risk varices miss rate. • The Baveno VI criteria can be applied to LS measurement by 2D-SWE.
© 2021. European Society of Radiology.

Entities:  

Keywords:  Elastography; Esophageal Varices; Liver Cirrhosis; Ultrasonography

Mesh:

Year:  2021        PMID: 34713329     DOI: 10.1007/s00330-021-08280-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  6 in total

1.  Liver Stiffness Detected by Shear Wave Elastography Predicts Esophageal Varices in Cirrhotic Patients.

Authors:  Jian-Bin Yu; Hui Xiong; Xin-Chun Yuan; Ai-Yun Zhou
Journal:  Ultrasound Q       Date:  2019-07-10       Impact factor: 1.657

2.  Reply.

Authors:  Barry M Berger; John B Kisiel; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2020-11-26       Impact factor: 11.382

3.  Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.

Authors:  Laurent Castéra; Juliette Foucher; Pierre-Henri Bernard; Françoise Carvalho; Daniele Allaix; Wassil Merrouche; Patrice Couzigou; Victor de Lédinghen
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

4.  Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients.

Authors:  Anita Paisant; Sylvain Lemoine; Christophe Cassinotto; Victor de Lédinghen; Maxime Ronot; Marie Irlès-Depé; Valérie Vilgrain; Brigitte Le Bail; Valérie Paradis; Clémence M Canivet; Sophie Michalak; Marie-Christine Rousselet; Pierre-Emmanuel Rautou; Jérôme Lebigot; Gilles Hunault; Anne Crouan; Christophe Aubé; Jérôme Boursier
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-16       Impact factor: 11.382

5.  Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.

Authors:  Young Seo Cho; Yongsoo Kim; Joo Hyun Sohn
Journal:  Ultraschall Med       Date:  2022-05-20       Impact factor: 5.445

6.  A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.

Authors:  Vikram Kotwal; Chimezie Mbachi; Yuchen Wang; Bashar Attar; Tejinder Randhawa; Estefania Flores; Julian Robles; Craig Rosenstengle; Melchor Demetria; Oluwatoyin Adeyemi; Gregory Huhn; Arvind R Murali
Journal:  Dig Dis Sci       Date:  2020-07-09       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.